Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/14426
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVAN DER SPEETEN, Kurt-
dc.contributor.authorStuart, O. Anthony-
dc.contributor.authorSugarbaker, Paul H.-
dc.date.accessioned2012-11-30T12:52:29Z-
dc.date.available2012-11-30T12:52:29Z-
dc.date.issued2012-
dc.identifier.citationSURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 21 (4), p. 577-597-
dc.identifier.issn1055-3207-
dc.identifier.urihttp://hdl.handle.net/1942/14426-
dc.description.abstractPeritoneal surface malignancy is a common manifestation of intra-abdominal malignancies. Systemic chemotherapy offers no long-term survival and poor quality of life for these patients in their terminal stages of disease. By contrast, cytoreductive surgery combined with perioperative intraperitoneal and intravenous chemotherapy has resulted in encouraging clinical results. Further improvements should come from both clinical phase II/III studies and pharmacologic research. This article reviews the current pharmacologic data and controversies regarding the perioperative intraperitoneal and intravenous application of chemotherapy.-
dc.language.isoen-
dc.publisherW B SAUNDERS CO-ELSEVIER INC-
dc.subject.otherOncology; Surgery; peritoneal metastases; pharmacology; intraperitoneal chemotherapy; intravenous chemotherapy-
dc.subject.otherPeritoneal metastases; Pharmacology; Intraperitoneal chemotherapy; Intravenous chemotherapy-
dc.titlePharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy-
dc.typeJournal Contribution-
dc.identifier.epage597-
dc.identifier.issue4-
dc.identifier.spage577-
dc.identifier.volume21-
local.format.pages22-
local.bibliographicCitation.jcatA1-
dc.description.notes[Van der Speeten, Kurt] Ziekenhuis Oost Limburg, Dept Surg Oncol, B-3600 Genk, Belgium. [Van der Speeten, Kurt] Univ Hasselt, Res Grp Oncol, Dept Med, Hasselt, Belgium. [Stuart, O. Anthony; Sugarbaker, Paul H.] Washington Hosp Ctr, Washington Canc Inst, Dept Surg Oncol, Washington, DC 20010 USA.-
local.publisher.placePHILADELPHIA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1016/j.soc.2012.07.013-
dc.identifier.isi000310403300007-
item.validationecoom 2013-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
item.fullcitationVAN DER SPEETEN, Kurt; Stuart, O. Anthony & Sugarbaker, Paul H. (2012) Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy. In: SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 21 (4), p. 577-597.-
item.contributorVAN DER SPEETEN, Kurt-
item.contributorStuart, O. Anthony-
item.contributorSugarbaker, Paul H.-
crisitem.journal.issn1055-3207-
crisitem.journal.eissn1558-5042-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

32
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

36
checked on Apr 30, 2024

Page view(s)

66
checked on Sep 6, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.